Opiant Pharmaceuticals Inc (NASDAQ:OPNT) Sellers Reduced By 8.58% Their Shorts

Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Corporate Logo

It was registered a decrease on Opiant Pharmaceuticals Inc (NASDAQ:OPNT)’s shorted shares with 8.58%. It was issued in January by FINRA the 142,700 shorted shares on OPNT. The 156,100 previous shares are down with 8.58%. With Average volume 24,700, OPNT’s previous position will take 6 days to restore.

OPNT reached $14.89 during the last trading session after $0.65 change.Currently Opiant Pharmaceuticals, Inc. is downtrending after 47.22% change in last January 10, 2018. OPNT has 16,512 shares volume. The stock underperformed the S&P500 by 47.22%.

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops opioid antagonist treatments for addictions and related disorders.The firm is valued at $57.11 million. The firm offers NARCAN nasal spray, a treatment to reverse opioid overdoses.Currently it has negative earnings. It is also involved in developing treatments for binge eating disorder and cocaine use disorder, as well as Bulimia Nervosa, an eating disorder; and heroin vaccine.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.